BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to CFPAC-1 cell line is 59
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SOX2 | 11195 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.5695 | 25811929 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 33737813 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 30853342 |
| SOX2 | 11195 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 29100320 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.1739 | 20372854 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by Western Blotting and qRT-PCR | NA | 0.48 | 0.1739 | 20372854 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.1739 | 30853342 |
| ABCG2 | 74 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | Gemcitabine | CFA followed by SFA and qRT-PCR | NA | 0.48 | 0.1739 | 19598259 |
| NANOG | 20857 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.5461 | 33737813 |
| NANOG | 20857 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 25811929 |
| NANOG | 20857 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.5461 | 29100320 |
| POU5F1 | 9221 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.6448 | 33737813 |
| POU5F1 | 9221 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 30853342 |
| POU5F1 | 9221 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.6448 | 29100320 |
| ABCB1 | 40 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0604 | 30853342 |
| ABCB1 | 40 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | Gemcitabine | CFA followed by SFA and qRT-PCR | NA | 0.28 | 0.0604 | 19598259 |
| ABCB1 | 40 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by qRT-PCR | NA | 0.28 | 0.0604 | 20372854 |
| ABCB1 | 40 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by qRT-PCR | NA | 0.28 | 0.0604 | 20372854 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.684 | 30853342 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | qRT-PCR | NA | 0.28 | 0.684 | 26035122 |
| ALDH1A1 | 402 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | ALDEFLUOR assay | NA | 0.28 | 0.684 | 24194908 |
| BMI1 | 1066 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1135 | 25811929 |
| CTNNB1 | 2514 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0647 | 25811929 |
| CTNNB1 | 2514 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by RT-PCR | NA | 0.28 | 0.0647 | 29100320 |
| CXCR4 | 2561 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0498 | 30853342 |
| FAM83A | 28210 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | Western Blotting followed by SFA and SP assay and Tumorigenicity assay | NA | 0.28 | 0.0011 | 28287611 |
| MYC | 7553 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 25811929 |
| ZG16B | 30456 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0021 | 29100320 |
| ABCC1 | 51 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | Gemcitabine | CFA followed by SFA and qRT-PCR | NA | 0.2 | 0.0212 | 19598259 |
| ABCC1 | 51 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.0212 | 20372854 |
| ABCC1 | 51 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by qRT-PCR | NA | 0.2 | 0.0212 | 20372854 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | qRT-PCR | NA | 0.2 | 0.456 | 26035122 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs | NA | 0.2 | 0.456 | 26398277 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.2 | 0.456 | 30853342 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.2 | 0.456 | 29100320 |
| CD24 | 1645 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by FACs | NA | 0.2 | 0.456 | 20372854 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | Gemcitabine | qRT-PCR | NA | 0.2 | 1 | 26035122 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | qRT-PCR | NA | 0.2 | 1 | 26035122 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | Gemcitabine | CFA followed by SFA and FACs | NA | 0.2 | 1 | 19598259 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs | NA | 0.2 | 1 | 26398277 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.2 | 1 | 30853342 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.2 | 1 | 29100320 |
| CD44 | 1681 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by FACs | NA | 0.2 | 1 | 20372854 |
| HOTAIR | 33510 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0011 | 33737813 |
| MET | 7029 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | qRT-PCR | NA | 0.2 | 0.0191 | 26035122 |
| MET | 7029 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0191 | 29100320 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | qRT-PCR | NA | 0.2 | 0.7582 | 26035122 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.7582 | 29100320 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs | NA | 0.2 | 0.7582 | 29029495 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs followed by SFA | NA | 0.2 | 0.7582 | 25811929 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.2 | 0.7582 | 30853342 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by FACs | NA | 0.2 | 0.7582 | 18829528 |
| PROM1 | 9454 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SP assay followed by FACs | NA | 0.2 | 0.7582 | 20372854 |
| STAT3 | 11364 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.0223 | 29100320 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs | NA | 0.12 | 0.211 | 26398277 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs | NA | 0.12 | 0.211 | 29029495 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.12 | 0.211 | 30853342 |
| EPCAM | 11529 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | SFA followed by FACs | NA | 0.12 | 0.211 | 29100320 |
| MALAT1 | 29665 | LTM | Pancreatic Cancer | Ductal Adenocarcinoma | CFPAC-1 | NA | FACs | NA | 0.12 | 0.0074 | 25811929 |